Close Menu

Miller School of Medicine

BOSTON (GenomeWeb Daily News) – While panelists at a session at the American Society of Human Genetics annual meeting on Saturday said that the public is cautiously interested in including whole-exome or whole-genome sequencing as part of newborn screening efforts, there are concerns regarding pr

This article has been updated to reflect that the clinical sequencing services will be integrated into existing CLIA laboratories.

Exiqon said last week that it has established a center of excellence at the Oncogenomics Core Facility at the Sylvester Comprehensive Care Center at the University of Miami Miller School of Medicine.

The gift from the John P. Hussman Foundation will support autism genomics studies.

The school will use the company's cancer diagnostic microarray to study ethnic differences in breast cancer.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.